Tag | Content |
---|
EnhancerAtlas ID | HS149-00325 |
Organism | Homo sapiens |
Tissue/cell | NKC |
Coordinate | chr13:41591240-41593360 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ZNF263 | MA0528.1 | chr13:41591718-41591739 | ACCCCCCCTTCTCCCTTCTCC | - | 6.55 |
|
| Number of super-enhancer constituents: 30 | ID | Coordinate | Tissue/cell |
SE_09221 | chr13:41588268-41594981 | CD14 | SE_10387 | chr13:41591054-41594336 | CD19_Primary | SE_10999 | chr13:41586782-41594964 | CD20 | SE_12017 | chr13:41591113-41594408 | CD3 | SE_12860 | chr13:41591107-41594210 | CD34_Primary_RO01480 | SE_13324 | chr13:41591123-41594688 | CD34_Primary_RO01536 | SE_14054 | chr13:41591043-41594008 | CD34_Primary_RO01549 | SE_14557 | chr13:41591019-41594655 | CD4_Memory_Primary_7pool | SE_17089 | chr13:41591090-41593939 | CD4p_CD225int_CD127p_Tmem | SE_17551 | chr13:41591106-41594888 | CD4p_CD25-_CD45RAp_Naive | SE_18001 | chr13:41587961-41594231 | CD4p_CD25-_CD45ROp_Memory | SE_18357 | chr13:41586465-41594682 | CD4p_CD25-_Il17-_PMAstim_Th | SE_20204 | chr13:41591008-41594260 | CD56 | SE_22365 | chr13:41591055-41594316 | CD8_primiary | SE_25440 | chr13:41591096-41594870 | DND41 | SE_26079 | chr13:41591111-41596208 | Duodenum_Smooth_Muscle | SE_27818 | chr13:41591048-41596772 | Fetal_Intestine | SE_28717 | chr13:41589113-41596566 | Fetal_Intestine_Large | SE_31205 | chr13:41591057-41594339 | Fetal_Thymus | SE_32532 | chr13:41591085-41593864 | GM12878 | SE_35394 | chr13:41591129-41595366 | HepG2 | SE_39455 | chr13:41591106-41593720 | Jurkat | SE_44094 | chr13:41591111-41593840 | MM1S | SE_55509 | chr13:41591230-41591759 | Thymus | SE_58302 | chr13:41534094-41596249 | Ly1 | SE_60466 | chr13:41534866-41594996 | DHL6 | SE_61682 | chr13:41555019-41595174 | Toledo | SE_62237 | chr13:41534318-41594936 | Tonsil | SE_64637 | chr13:41591143-41594546 | NHEK | SE_66291 | chr13:41591106-41593720 | Jurkat |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | ACAGTGAAAA ACAAAAAGTT GTTGTAGAAA TAAAATGAAT GCATCATCTT TCTGATGAAA 60 AAGAAAACTA CATTTTCAAA ATCATTGGTT GATCCATTTG GTTGCAACTT ATCACCAAGA 120 TTATCACCAA ACATCTTAAT TAAGGTTTTA TTTACTCTTA AGGAAATATA GAGCATTTCA 180 AACAAAGCAT CACTTGTGAC TGGCACAAGC AGTTCCAGAC TGCGAAGCCC TGCCATTAGG 240 TACTGCATGA CCTCAAGCAA ATCACAGGAC CTCTGTGGGC CACTGTTTCT TCATCTATAA 300 AAGTGAGGCA GTTGGACAAT CTTCAGTCAC TTTCAGCACT AAAGTTCTAT AAATCACTAA 360 TTCTAAATTT AATTCTGATG GGTCAGTTCA AACTTACATT CAATCTTATG GAAGGAAAAA 420 CGTGGAGAGG GAAATACTTA ATAAATTGTT CTGGTCTTTT CTTGGTTCTC TTCTTTTTAC 480 CCCCCCTTCT CCCTTCTCCT TGAAACTCCA CTTCAGTCTC TATCACGTAA GAAAATACAT 540 AAACAATATC TATACTACTT TAACTGTACC AGCTTCTTAA ATTTAAGAAA CCAAATTCCT 600 CTACTTCTCT TTAATAAATA AGATCTTAAT TATGCCGCTT ATTTGTGTGC CTCTTGATTT 660 TTCTCTTATG GATCACCACC TTAAAAAAGT TAAAAAAAAA AATAGAAAAG TCTTCATTAG 720 ATTTTTCACA CAGACCAGAC TAGAAGTAAA TACAGCTTTT GCTTACTCAA AGGCTGACTA 780 AACCAGCAAT ATGCAAACAA AGATGATAGC AAATGGCTCA GCTGAATTGG TAAAATGTCC 840 GCTGTGTCTT TCTTGTAAGA CCGCAAAATT GAGATCTGTT AATATCAACA ATCCTTACAA 900 AAGAGTAAGA AATAATAACT GATTGCCTTT GTCTCTTCCC TTTAATCTGA CAGGCCTTCA 960 AGCACTTAGT AAGTGCATAG CAAATTCTCA AAGAACTAGC TAAATATCAT TTTGGTCAAC 1020 AAGAAATGAT TTGGCAAGTT TTATATCCAA AAACTTTATT TTTTGGAATC ACTGCATATT 1080 CCAATTTTAT CTTCATAAAT ATGTTTCAGA AATAAAATAC TACTGCACTC ATCTTTACAG 1140 AGCACCTAGA ACTTTAAGGC ACAGTAGGAT GTATACTTGC CAGCCAAAAT CTCATAACTA 1200 CAATGACAAG TACTTCAGGA AAAGACTGAG CAATCTTTTC ATTTACAGAA GGTTTTTAAT 1260 TCAAGGCAGG CAAATTTTAA GAACAGTAAT ACAAAAGGAA GGCCAATACT CATCACTTTT 1320 TCTTTTTACA CAAAATTGAA ATAACTACGT TTCCTTAGAA GACAGCTTTA CTTCTAAGGT 1380 TGTTACTCAG AACAAGTTTT CAGTGTGAAT TATAAAACTT CATTTTTTTC TAATAGTAAA 1440 TGAATCATTC TAGTCTTTCT TCCTCTATTT AATATTCACT TTTACTTGTT ATCTAAATAA 1500 TCTAATATTC ATTTTTACTT ATTATCTAAA TAACAATTCA TTTAAATTTC CATTGGGTTT 1560 CCAAAATGAA ACATTTAATA TAATTTCATT AACTTTAAAA AACAGAGAGG GAGAAAAAAA 1620 TAAATAAATA ACAGTCAATG AGCAACACCT ATGGCTGAGT TGTCCCAAAA CTTCACCCTT 1680 AGCTAAAATG CCAAAACAAA GCCACTGCCC CTGGATATTT AACATCTATA TCACACAGGA 1740 ATAATACGGT TTACTTAACT GTAACTTCAA CTACCCCAAA AAATACAATT AGGTTTTTTA 1800 AATTAAAATT TGACCTTAGT TTGCTTTGTG GTACTTAAAA ACAAATAAAC AAACAAAAAA 1860 CCTCTTTTAT TCTTAAATTA CATAGAAAAA AAATCACAAA GACATACAAA ATGCTTTAGC 1920 AAGAAGATCT AAAACTTTCC AGAATTTCAG TGCTTTGTTT CCCCCTAGCA ATTAAGTTCA 1980 ATCAGGCATG TGACTGACCA CACACATTTT ATCAGAGGGT TAAAGAACAC ATTCAGCCAT 2040 GTTCTTCAAC AGGTAAGAAC CACCCTCTGT TTATCAGCTC AAGAAAAAGC CAGAAGCAAA 2100 CATACAAAAT TGTAACAAGT 2120
|